本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

阿尔尼拉姆制药公司

328.81
+0.81000.25%
盘后328.810.00000.00%18:35 EDT
成交量:66.67万
成交额:2.19亿
市值:428.73亿
市盈率:-156.71
高:331.50
开:331.50
低:324.55
收:328.00
数据加载中...
2025/02/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/31

重要事件披露

Form 8-K - Current report
2024/08/22

SEC问询函

Form CORRESP - Correspondence
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/01

重要事件披露

Form 8-K - Current report
2024/07/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities